Howard B. Rosen

Insider Reports History

Location
Redwood City, CA
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Howard B. Rosen:

Company Role Class Num Shares Value Price $ Report Date Ownership
KALA BIO, Inc. Director Common Stock 16,240 $65,609 $4.04 15 Jun 2025 Direct
ACELRX PHARMACEUTICALS INC Director Common Stock 5,293 $3,847 $0.7268 10 Oct 2023 Direct
KALA BIO, Inc. Director Common Stock 262 $1,058 $4.04 15 Jun 2025 Indirect
KALA BIO, Inc. Director Stock Option (right to buy) 5,450 15 Jun 2025 Direct
ACELRX PHARMACEUTICALS INC Director Stock Option (Right to Buy) 3,487 10 Oct 2023 Direct

Insider Reports Filed by Howard B. Rosen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KALA KALA BIO, Inc. 15 Jun 2025 2 $0 4 Director 17 Jun 2025, 20:00
KALA KALA BIO, Inc. 11 Jun 2024 2 $0 4 Director 12 Jun 2024, 20:00
TLPH ACELRX PHARMACEUTICALS INC 10 Oct 2023 2 $0 4 Director 13 Dec 2023, 16:21
KALA Kala Pharmaceuticals, Inc. 22 Jun 2023 4 $0 4 Director 23 Jun 2023, 20:00
KALA Kala Pharmaceuticals, Inc. 31 May 2023 6 $0 4 Director 02 Jun 2023, 20:00
TLPH ACELRX PHARMACEUTICALS INC 15 Jul 2022 2 $0 4 Director 15 Jul 2022, 19:27
KALA Kala Pharmaceuticals, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:45
KALA Kala Pharmaceuticals, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 17:31
TLPH ACELRX PHARMACEUTICALS INC 17 Jun 2021 2 $0 4 Director 17 Jun 2021, 17:31